Skip to content
DHEA·Compass

Safety Reference · DHEA

DHEA Side Effects: What to Watch For

DHEA at reasonable doses is broadly well tolerated — and decidedly not free of consequence. A sober, dose-aware look at the actual side-effect profile in women and men, including the dermatologic effects most people don’t realize are dose-related.

Get a Personalized Hormone Plan Jump to contents →
Editorial photograph of a stethoscope on a modern medical surface
DHEA is a hormone, not a vitamin — and the side-effect profile follows hormone pharmacology, not supplement pharmacology.

The headline claim of OTC DHEA marketing is that the side-effect profile is mild because DHEA is “natural.” Both halves of that claim do something for the manufacturer’s comfort and very little for the user’s. DHEA at typical doses is reasonably well tolerated. It is also a hormone, and at the wrong dose for the wrong patient it produces consistent, predictable problems.

The Clinical Reality

The DHEA side-effect profile in the published literature is dominated by androgenic effects — the consequences of DHEA being converted into testosterone in tissues that have the enzymatic machinery to do so. The dose-response is real: at 10 mg/day, side effects are uncommon; at 50 mg/day, they are common; at 100 mg/day, they are nearly universal in women.

The other major cluster of issues comes from the fact that DHEA is a precursor for estrogen as well, which is relevant for women with hormone-sensitive conditions and for men with sensitivity to aromatization.

Side Effects Specific to Women

Women experience the androgenic side-effect cluster more readily than men, for the simple reason that women have lower baseline androgens and a larger proportional response to a given DHEA dose:

  • Acne — particularly cystic and along the jawline.
  • Oily skin and oily scalp.
  • Increased facial or body hair (chin, upper lip, abdomen).
  • Scalp hair thinning at the part line.
  • Menstrual cycle irregularity, particularly in perimenopausal women.
  • Mood swings, irritability, or anxiety.
  • Sleep disruption — especially with evening dosing.
  • Reduced fertility (transient, related to ovulatory disruption).

These are not rare. They are common enough that the Endocrine Society’s clinical practice guideline specifically calls out the risk of androgenic effects when discussing DHEA dosing in women.

Acne and Oily Skin

DHEA converts in sebaceous glands into testosterone, which drives sebum production and follicle proliferation. The consequence is dose-related acne, particularly along the jawline and on the back. This is one of the earliest and most reliable signals that a DHEA dose is too high for the individual.

The typical timeline:

  • 2–4 weeks after starting: mild oiliness, occasional new lesions.
  • 4–8 weeks: established jawline acne if the dose is too high.
  • Reduction of dose or discontinuation: improvement within 4–6 weeks.

Hair Changes

The dermatologic effect that most often causes women to discontinue DHEA is scalp hair thinning. The mechanism: DHEA converts in hair follicles into dihydrotestosterone, which is the primary mediator of androgenetic alopecia.

In women who are not predisposed to androgenetic alopecia, this is uncommon. In women who are predisposed (a polygenic trait affecting an estimated 40% of women by age 70), even a 25 mg/day dose can accelerate visible thinning at the part line. The hair lost via this mechanism may not fully recover after discontinuation if the alopecia process has been activated.

Conversely, women may also experience unwanted hair growth — facial hair, increased body hair — at higher doses. This is hirsutism driven by the same DHEA-to-testosterone conversion in a different tissue.

Editorial chart of side-effect dose-response curves
The androgenic side-effect rate of DHEA rises sharply between 25 mg/day and 50 mg/day in women.

Mood Changes and Sleep Disruption

DHEA has documented effects on neurosteroid pathways, particularly GABA-A receptors. The mood effects are heterogeneous: some women report improved mood (the basis for the antidepressant-adjunct evidence base), while others report irritability, anxiety, or mood swings. The variability is not yet well predicted by baseline characteristics.

Sleep disruption is particularly common with evening dosing. The mechanism is partly the alerting effect of DHEA metabolites and partly the disruption of the natural circadian cortisol/DHEA rhythm. Switching to morning dosing resolves most evening-DHEA-related insomnia.

Hormonal Imbalances From Overdosing

The most clinically meaningful overdose syndrome is supraphysiologic elevation of DHEA-S, testosterone, and estradiol. The consequences:

  • Androgenic effects (acne, hirsutism, alopecia) — covered above.
  • Menstrual disruption in premenopausal women.
  • Endometrial proliferation in postmenopausal women (theoretical, more commonly seen with higher and prolonged doses).
  • Mood and sleep symptoms.
  • In men, gynecomastia and breast tenderness from aromatization.

The good news: nearly all of these are reversible by reducing or stopping DHEA. The bad news: they often appear weeks-to-months into supplementation, after the user has invested time in the protocol — which makes them clinically frustrating.

Drug Interactions

  • Hormone therapy. Combining oral DHEA with estrogen, testosterone, or progesterone therapy compounds the hormonal load and requires monitoring.
  • Oral contraceptives. OCPs suppress endogenous DHEA-S; supplementing in this setting may be appropriate or unnecessary depending on context.
  • Anticoagulants (warfarin, DOACs). Theoretical interaction via hepatic enzyme effects; monitor INR if applicable.
  • Antidepressants. Particularly MAOIs and SSRIs — possible neurosteroid interactions; clinical significance not well established.
  • Corticosteroids. May modify DHEA effects via shared adrenal pathway.
  • Anti-androgens (spironolactone, finasteride). DHEA supplementation works against the therapeutic effect.
  • Aromatase inhibitors. In women on anastrozole or letrozole for breast cancer, DHEA may provide additional estrogen-precursor substrate — explicitly contraindicated.

Who Should Not Take DHEA

Several populations have either absolute or relative contraindications, drawn from current guidelines:

  • Pregnant or breastfeeding women — absolute.
  • Women with a history of estrogen-receptor-positive breast cancer — explicit Endocrine Society recommendation against.
  • Women with hormone-sensitive ovarian or uterine cancers.
  • Women with severe PCOS or already-elevated DHEA-S.
  • Adolescents — endogenous adrenal androgen production is still maturing.
  • Individuals with active liver disease.
  • Men with prostate cancer or active BPH.
  • Anyone with known sensitivity to DHEA products.

How to Minimize Side Effects

  1. Get a baseline. Don’t start without DHEA-S, estradiol, and testosterone numbers. Most preventable side effects come from supplementing into already-adequate levels.
  2. Start low. 5–10 mg/day in women; 10–25 mg/day in men. Increase only if labs and symptoms justify it.
  3. Time it correctly. Morning, with food. Evening dosing produces unnecessary sleep disruption.
  4. Choose third-party-tested products. Inconsistent dose is a major source of inconsistent side effects.
  5. Retest at 8–12 weeks. The supplement is doing something measurable; verify what.
  6. Watch the early signals. Acne, oily skin, scalp thinning are early dose-response signals. Don’t push through them.
  7. Have a prescriber in the loop. A clinician who reads your labs is a far better safety net than online dosing advice.

Editor’s recommendation

Get a clinician in the loop before you escalate the dose.

A 4-minute intake matches you with a hormone-trained, US-licensed clinician who reviews your DHEA-S, estradiol, and testosterone — and tells you whether the side effect you’re experiencing means dose adjustment, switch in approach, or stop entirely.

Talk to a Clinician

Free intake · No card required · Reviewed by a US-licensed clinician

FAQ

Reader Questions

The questions readers send us most when they start digging into DHEA.

What are the most common side effects of DHEA?

In women, the most common side effects are acne, oily skin, increased facial or body hair, scalp hair thinning, and menstrual irregularity. In men, the most common side effects are gynecomastia (paradoxical, from aromatization to estradiol), oily skin, and changes in libido.

How long do DHEA side effects last?

Most androgenic side effects resolve within 4–8 weeks of stopping DHEA. Acne and oily skin typically improve fastest; hirsutism may take longer to reverse. Scalp hair thinning may not fully reverse if androgenetic alopecia has been activated.

Can DHEA cause hair loss?

Yes. DHEA converts into testosterone and dihydrotestosterone in hair follicles. In women predisposed to androgenetic alopecia, even modest doses can accelerate visible scalp thinning. This is one of the most common reasons women discontinue OTC DHEA.

Can DHEA cause acne?

Yes — acne is one of the most common dose-dependent side effects in women. Jawline and cystic acne is particularly characteristic.

Does DHEA cause weight gain?

Regular DHEA has not been shown to cause significant weight gain in controlled trials. Some women report mild fluid retention or appetite changes in the first few weeks; these are usually transient.

Can DHEA cause mood changes?

Yes, particularly at higher doses. Reported effects include irritability, anxiety, mood swings, and in some cases improved mood. Effects appear to be more pronounced in women than men.

Does DHEA interact with other medications?

Yes. DHEA can interact with hormone therapies (estrogen, testosterone, contraceptives), anticoagulants, antidepressants, and corticosteroids. Always disclose DHEA supplementation to every prescriber.

Who should not take DHEA?

Pregnant or breastfeeding women, women with a history of hormone-sensitive cancers (especially ER+ breast cancer), women with severe PCOS or already-elevated DHEA-S, individuals with active liver disease, and adolescents (whose endogenous DHEA production is still maturing).

Sources

References & Further Reading

All claims on this page are anchored to peer-reviewed clinical literature, federal regulatory documents, or position statements from major endocrine societies.

  1. NIH ODS — DHEA safety information
  2. Endocrine Society — DHEA guideline
  3. Panjari M & Davis SR — Adverse events with DHEA in women
  4. FDA MedWatch — DHEA adverse event reports
  5. Davis SR — DHEA in women position statement
Personalized Plan